These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6766162)

  • 1. Native and activated properdin: interconvertibility and identity of amino- and carboxy-terminal sequences.
    Medicus RG; Esser AF; Fernandez HN; Müller-Eberhard HJ
    J Immunol; 1980 Feb; 124(2):602-6. PubMed ID: 6766162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative pathway of complement: nonenzymatic, reversible transition of precursor to active properdin.
    Götze O; Medicus RG; Müller-Eberhard HJ
    J Immunol; 1977 Feb; 118(2):525-32. PubMed ID: 839069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of rabbit properdin of the alternative complement pathway.
    Nakano Y; Matsuda T; Sakamoto T; Tomita M
    J Immunol Methods; 1986 Jun; 90(1):77-83. PubMed ID: 3635564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of native properdin by reversed affinity chromatography and its activation by proteolytic enzymes.
    Minta JO
    J Immunol; 1976 Aug; 117(2):405-12. PubMed ID: 950461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the natural polymeric forms of human properdin and their functions in complement activation.
    Pangburn MK
    J Immunol; 1989 Jan; 142(1):202-7. PubMed ID: 2909614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
    Naff GB; Hedrick SW; Ratnoff WD; Novak MA; Smith MC; Steiner C; Todd EW
    J Immunol; 1980 Jun; 124(6):2625-31. PubMed ID: 6900053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and characterisation of the thrombospondin type I repeats of human properdin.
    Perdikoulis MV; Kishore U; Reid KB
    Biochim Biophys Acta; 2001 Aug; 1548(2):265-77. PubMed ID: 11513971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fractionation of human plasma proteins. I. Affinity purification of human complement properdin.
    DiScipio RG
    Protein Expr Purif; 1994 Apr; 5(2):164-9. PubMed ID: 8054850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and functional analysis of human properdin.
    O'Flynn J; Krol MC; Daha MR; van Kooten C
    Methods Mol Biol; 2014; 1100():161-7. PubMed ID: 24218258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modelling.
    Sun Z; Reid KB; Perkins SJ
    J Mol Biol; 2004 Nov; 343(5):1327-43. PubMed ID: 15491616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution and analysis of 'native' and 'activated' properdin.
    Farries TC; Finch JT; Lachmann PJ; Harrison RA
    Biochem J; 1987 Apr; 243(2):507-17. PubMed ID: 3307764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and partial characterization of a preneoplastic antigen in liver carcinogenesis.
    Lin JC; Kligman L; Farber E
    Cancer Res; 1980 Oct; 40(10):3755-62. PubMed ID: 7438059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational analysis of peptide fragments derived from the peripheral subunit-binding domain from the pyruvate dehydrogenase multienzyme complex of Bacillus stearothermophilus: evidence for nonrandom structure in the unfolded state.
    Spector S; Rosconi M; Raleigh DP
    Biopolymers; 1999 Jan; 49(1):29-40. PubMed ID: 10070261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple method for isolation of human properdin by affinity chromatography.
    Konno T; Hirai H
    J Immunol Methods; 1976; 12(1-2):47-55. PubMed ID: 792350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal-dependent conformational changes in a recombinant vWF-A domain from human factor B: a solution study by circular dichroism, fourier transform infrared and (1)H NMR spectroscopy.
    Hinshelwood J; Perkins SJ
    J Mol Biol; 2000 Apr; 298(1):135-47. PubMed ID: 10756110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
    Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
    Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active sites in complement component C3 mapped by mutations at indels.
    Ogata RT; Ai R; Low PJ
    J Immunol; 1998 Nov; 161(9):4785-94. PubMed ID: 9794410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.